← Open Payments lookup

CATHERINE O'NEILL: Open Payments

NPI 1407455116 · CONCORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,435 in 48 payments from 11 companies in 2025. Trend: 2023 $1,758 · 2024 $1,001 · 2025 $1,435

Food & beverage: $1,336Education: $99
CompanyPaymentsAmount
GlaxoSmithKline, LLC.8$289
Regeneron Healthcare Solutions, Inc.10$242
ARS Pharmaceuticals Operations, Inc.6$238
AstraZeneca Pharmaceuticals LP4$199
CSL Behring3$153
GENZYME CORPORATION8$148
Novartis Pharmaceuticals Corporation4$79
Amgen Inc.2$28
Genentech USA, Inc.1$22
Optinose US, Inc.1$18

Products named: DUPIXENT, NUCALA, NEFFY, TEZSPIRE, Andembry, AYVAKIT, FASENRA, TRELEGY ELLIPTA.

Industry payments across CA — which companies pay providers there.